MedPath

Construction of therapeutic evidence for active ulcerative colitis requiring hospitalizatio

Not Applicable
Conditions
ulcerative colitis
Registration Number
JPRN-UMIN000041062
Lead Sponsor
Kansai Medical University
Brief Summary

Most first-use advaned therapy (ATs) were effective for patients with Acute severe, while second-use ATs might have had limited benefits in inducing clinical remission. These findings may contribute to considerations for the management of hospitalized patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) Outpatients 2) Colitis other than ulcerative colitis (e.g. infectious colitis) 3) Patients who will receive total colectomy 4) Patients judged to be inappropriate for inclusion in this study 5) Patients participate other clinical trial.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath